PL3082805T3 - Podstawione amino-triazole i sposoby z ich użyciem - Google Patents

Podstawione amino-triazole i sposoby z ich użyciem

Info

Publication number
PL3082805T3
PL3082805T3 PL14871777T PL14871777T PL3082805T3 PL 3082805 T3 PL3082805 T3 PL 3082805T3 PL 14871777 T PL14871777 T PL 14871777T PL 14871777 T PL14871777 T PL 14871777T PL 3082805 T3 PL3082805 T3 PL 3082805T3
Authority
PL
Poland
Prior art keywords
methods
same
substituted amino
amino triazoles
triazoles
Prior art date
Application number
PL14871777T
Other languages
English (en)
Inventor
Michael L. CORMAN
William M. HUNGERFORD
Adam Golebiowski
Raymond P. Beckett
Marzena MAZUR
Sylwia OLEJNICZAK
Jacek OLCZAK
Original Assignee
Institute For Drug Discovery, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute For Drug Discovery, Llc filed Critical Institute For Drug Discovery, Llc
Publication of PL3082805T3 publication Critical patent/PL3082805T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
PL14871777T 2013-12-20 2014-12-19 Podstawione amino-triazole i sposoby z ich użyciem PL3082805T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361919117P 2013-12-20 2013-12-20
PCT/US2014/071490 WO2015095701A1 (en) 2013-12-20 2014-12-19 Substituted amino triazoles, and methods using same
EP14871777.0A EP3082805B1 (en) 2013-12-20 2014-12-19 Substituted amino triazoles, and methods using same

Publications (1)

Publication Number Publication Date
PL3082805T3 true PL3082805T3 (pl) 2020-09-21

Family

ID=53403739

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14871777T PL3082805T3 (pl) 2013-12-20 2014-12-19 Podstawione amino-triazole i sposoby z ich użyciem

Country Status (9)

Country Link
US (1) US10214531B2 (pl)
EP (1) EP3082805B1 (pl)
JP (1) JP2017501226A (pl)
CN (1) CN106659715A (pl)
AU (1) AU2014369053B2 (pl)
CA (1) CA2937147A1 (pl)
PL (1) PL3082805T3 (pl)
SG (1) SG11201605757SA (pl)
WO (1) WO2015095701A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6836502B2 (ja) * 2014-05-30 2021-03-03 スプハエラ ファーマ ピーヴィーティー リミテッド 抗結核薬としての新規な化合物
PL415073A1 (pl) * 2014-12-19 2016-06-20 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
EP3331886B1 (en) * 2015-08-05 2020-07-15 Indivior UK Limited Dopamine d3 receptor antagonists having a bicyclo moiety
PL415078A1 (pl) 2015-09-04 2017-03-13 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
CN117466803A (zh) 2017-08-21 2024-01-30 阿卡蒂亚药品公司 化合物、其盐和用于治疗疾病的方法
EP3672960A2 (en) * 2017-08-21 2020-07-01 Acadia Pharmaceuticals Inc. Compounds, salts thereof and their use for the treatment of diseases
ES2910071T3 (es) 2018-03-08 2022-05-11 Incyte Corp Compuestos de aminopirazina diol como inhibidores de PI3K-Y
CN108467395B (zh) * 2018-05-09 2020-12-11 大连理工大学 一种几丁质酶抑制剂及其应用
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
AU2020311940A1 (en) 2019-07-11 2022-02-03 ESCAPE Bio, Inc. Indazoles and azaindazoles as LRRK2 inhibitors
MX2022002881A (es) * 2019-09-25 2022-06-08 Oncoarendi Therapeutics Sa Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina.
BR112022012643A2 (pt) * 2020-01-28 2022-09-06 Evotec Int Gmbh Moduladores da via de resposta ao estresse integrada
CN111732571B (zh) * 2020-07-24 2021-06-29 广西壮族自治区农业科学院 一种用于防治香蕉枯萎病的杀植物真菌剂
CN114835687B (zh) * 2021-04-02 2023-09-05 北京华森英诺生物科技有限公司 AhR抑制剂
CA3220039A1 (en) 2021-06-14 2022-12-22 Jr. David St. Jean Urea derivatives which can be used to treat cancer
US20230348516A1 (en) * 2022-04-29 2023-11-02 Molecure S.A. Ykl-40 inhibitors and their therapeutic applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421753A (en) * 1982-01-15 1983-12-20 American Cyanamid Company 1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines
US4582833A (en) * 1984-04-16 1986-04-15 American Cyanamid Company 2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
GB0325745D0 (en) * 2003-11-05 2003-12-10 Astrazeneca Ab Chemical compounds
JP2008542322A (ja) 2005-06-01 2008-11-27 ユセベ ファルマ ソシエテ アノニム 2−オキソ−1−ピロリジン誘導体
US8288371B2 (en) 2007-10-05 2012-10-16 Pharmacopeia, Llc Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
AU2012230348A1 (en) * 2011-03-24 2013-08-29 Cellzome Limited Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators

Also Published As

Publication number Publication date
SG11201605757SA (en) 2016-08-30
AU2014369053B2 (en) 2019-03-14
AU2014369053A1 (en) 2016-07-28
CN106659715A (zh) 2017-05-10
WO2015095701A1 (en) 2015-06-25
EP3082805B1 (en) 2020-02-05
US10214531B2 (en) 2019-02-26
EP3082805A4 (en) 2017-05-10
US20160297823A1 (en) 2016-10-13
JP2017501226A (ja) 2017-01-12
EP3082805A1 (en) 2016-10-26
CA2937147A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
IL276106A (en) Garp-binding proteins and their uses
SG11201605757SA (en) Substituted amino triazoles, and methods using same
GB201319878D0 (en) Method, Array and use thereof
GB201306633D0 (en) Biaising circuitry and method thereof
HK1198908A1 (en) Beauty aid
EP3012292A4 (en) TREATMENT ADJUVANT, AND COMPOSITION
IL240248A0 (en) Met-binding substances and their uses
GB201312318D0 (en) Novel methods and compounds
GB201300376D0 (en) Method and compound
IL239762B (en) Selective nox-1 blocking peptides and their use
ZA201507580B (en) Urea mixtures and methods for making and using same
GB201308057D0 (en) Protein
GB201313803D0 (en) Fungicidal composition and method
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
SI3033532T1 (sl) Vezni element, uporaba in postopek
GB201401955D0 (en) Protein
ZA201601880B (en) Hetero-transglycosylase and uses thereof
EP3015549A4 (en) NOVEL POLYPEPTIDE AND USE THEREOF
GB201301640D0 (en) Methods and peptides
GB201302030D0 (en) Protein
GB201302031D0 (en) Protein
GB201315291D0 (en) Compound and method
GB201315298D0 (en) Compound and method
GB201315296D0 (en) Compound and method
GB201315292D0 (en) Compound and method